Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
66

Summary

Conditions
  • Advanced Cancer
  • Metastatic Cancer
  • Neoplasms
  • Non -Small Cell Lung Cancer
  • Non Small Cell Lung Cancer Metastatic
  • Non Small Cell Lung Cancer Stage IIIB
  • Solid Tumor
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03307785
Collaborators
Not Provided
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline